Navigation Links
Recurrent Stroke Risk is Minimized by Statin

According to a five-year study led by an international team that includes a researcher at Duke University Medical Center, the risk of recurrent stroke// is reduced by 16%, in people who have no known history of coronary heart disease and start on a regular treatment with atorvastatin, a cholesterol-lowering drug

The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, the results of the study, is published in the 10th August 2006 issue of the New England Journal of Medicine. Pfizer, the company which manufactures atorvastatin, funded this study.

"This is the first study to demonstrate that treatment with a statin, a type of cholesterol-lowering drug, can reduce the risk of strokes in patients who have had a recent stroke or a transient ischemic attack and who have no known history of coronary heart disease," said Larry B. Goldstein, M.D., director of the Duke Stroke Center and a member of the SPARCL steering committee.

A transient ischemic attack is similar to a stroke, but is of shorter duration and severity. Often referred to as a ministroke, it is considered a warning sign or prelude for stroke.

"These results will have a major effect on how people are treated following a stroke," Goldstein said. "The findings are very important for physicians and patients because they show that the addition of this drug to other treatments further reduces the risk of another stroke, which is a pretty big step in improving what we can do for stroke patients."

Previous studies, Goldstein said, have demonstrated that atorvastatin and other drugs within the class of medications called statins could reduce risk of stroke in patients who have a history of coronary disease. Coronary heart disease is a narrowing of the small blood vessels that supply blood to the heart, usually due to a build-up of cholesterol. It is a leading cause of death for Americans, he added.

The study results showed that ato
'"/>




Page: 1 2 3

Related medicine news :

1. Estrogen Does Not Prevent Recurrent Strokes
2. Radiation Therapy An Effective Solution For Recurrent Prostate Cancer
3. Prevention Of Recurrent Leg Ulcers
4. Measuring Urinary Protein Helps In Detecting Recurrent Bladder Cancer
5. Sertraline Can Prevent Recurrent Depressive Episodes In Diabetics
6. Angola Warned of Recurrent Cholera Outbreaks
7. Gemzar the New Drug for Recurrent Ovarian Cancer
8. Blood Markers Predict Risk for Recurrent Stroke and Mortality
9. Targeted Compound Helps Recurrent Prostate Cancer Patients
10. Ancient Indian Herb May Prove Cure For Recurrent UTI
11. Amphetamines Help Recovery of Stroke Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Recurrent Stroke Risk Minimized Statin

(Date:4/14/2014)... Henry Ford Hospital reached a medical milestone April ... using a novel way to access the heart. ... the United States performing the unique procedure called ... temporarily connecting major blood vessels. , Northern Michigan ... transcaval procedure on July 3, 2013 when traditional ...
(Date:4/14/2014)... in their radiation treatment decisions leaves cancer patients ... even relieve psychological distress around the experience, researchers ... the University of Pennsylvania report in the ... of 305 patients undergoing radiation treatment, Neha ... department in Radiation Oncology at Penn Medicine, and ...
(Date:4/14/2014)... microRNA 135b, is a vital ,worker, employed by several ... cancers. , Drugs targeted at the microRNA could knock ... while tests for it could identify patients with the ... was carried out by an international team including scientists ... University of Glasgow and Ohio State University in the ...
(Date:4/14/2014)... more evidence that antibiotics can contribute to obesity. ... journal Antimicrobial Agents and Chemotherapy suggests ... and had significant changes in their gut microbiota. ... of Aix-Marseille University, Marseille, France, followed 48 patients ... hydroxychloroquine for Q fever, and 34 control subjects. ...
(Date:4/14/2014)... a decade Chang Lu, associate professor of chemical engineering ... development of tools to efficiently analyze living cells. The ... a range of diseases. , In his lab ... micrometer features for examining molecular events inside cells. These ... studying a low number of cells. , Based on ...
Breaking Medicine News(10 mins):Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Shared decision making during radiation therapy improves patient satisfaction 2Health News:Shared decision making during radiation therapy improves patient satisfaction 3Health News:'MicroRNA' could be key target for bowel cancer treatment 2Health News:Long-term antibiotic treatment for Q fever causes weight gain 2Health News:Efficient analysis of small quantity of cells improves chances to understand disease 2
... findings released today indicate that Americans awareness of nanotechnology ... the tiny nanoscale materials and nano-enabled devices and products ... technology that experts believe will usher in a new ... most Americans continue to prefer that government, not industry, ...
... Technologies Inc., a privately,held orthobiologics company, today announced that ... clearance for InQu(TM). InQu is,indicated for use as a ... bone graft,substitute in the extremities and pelvis. InQu ... optimize structural and biological properties to support bone cell,growth. ...
... as depressed, distraught were seldom questioned, study found , , ... disconnect between doctors and some of their neediest patients, ... fail to spot symptoms that raise suicide risk. ... and visit physicians while showing signs of depression or ...
... Cornell University will host more than 200 physicians ... the Northeast Wilderness Medical Conference, Sept. 26-28. Those attending ... by grappling with similar circumstances encountered in the wilderness., ... 11, 2001, disaster in New York City and the ...
... ... Disease, WHITE PLAINS, N.Y., ... with Hodgkin,lymphoma will put the blood cancer in focus. With more than ... awareness about Hodgkin lymphoma and other blood cancers. Hodgkin lymphoma begins ...
... dad in decision-making, researchers say , MONDAY, Sept. 24 (HealthDay ... participate in medical decisions made about their children while in ... parents, published in the October issue of the Journal ... confident talking with doctors, and parents whose child had been ...
Cached Medicine News:Health News:Poll reveals public awareness of nanotech stuck at low level 2Health News:Poll reveals public awareness of nanotech stuck at low level 3Health News:ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender 2Health News:Doctors Often Fail to Spot Suicidal Patients 2Health News:Doctors Often Fail to Spot Suicidal Patients 3Health News:In the Neighborhood: Blood Cancer Strikes Wisteria Lane 2Health News:Most Parents Have Say in Kids' Hospital Care 2
(Date:1/15/2014)... 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ... decade has seen the atopic dermatitis market ...
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014 /PRNewswire/ ... addressing the unmet needs of severely obese patients, ... study of beloranib, a selective inhibitor of methionine ... (PWS), a severe form of genetic obesity.  These ... and body composition, including reductions in body fat ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the ... the Miami Beach Convention Center ... More than 3,500 attendees from top ... part in the conference, which includes on-site education sessions, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... part of the Freedom Urinary Collection ... bags, kits, and accessories designed to ... customers. These leg bags are offered ... 100% latex-free soft, textured medical grade ...
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
Medicine Products: